Glaucoma medical therapy: Difference between revisions

Jump to navigation Jump to search
Line 26: Line 26:
====Cannabis====
====Cannabis====
Studies in the 1970s showed that [[Cannabis (drug)|marijuana]], when smoked, lowers intraocular pressure.<ref name="AOA">American Academy of Ophthalmology.[http://www.aao.org/education/library/cta/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=1216 Complementary Therapy Assessment: Marijuana in the Treatment of Glaucoma.] Retrieved August 2, 2006.</ref> In an effort to determine whether marijuana, or drugs derived from marijuana, might be effective as a glaucoma treatment, the US National Eye Institute supported research studies from 1978 to 1984. These studies demonstrated that some derivatives of marijuana lowered intraocular pressure when administered orally, intravenously, or by smoking, but not when topically applied to the eye. Many of these studies demonstrated that marijuana&mdash; or any of its components &mdash; could safely and effectively lower intraocular pressure more than a variety of drugs then on the market. In 2003, the [[American Academy of Ophthalmology]] released a position statement asserting that "no scientific evidence has been found that demonstrates increased benefits and/or diminished risks of marijuana use to treat glaucoma compared with the wide variety of pharmaceutical agents now available."<ref name="AOA"/>
Studies in the 1970s showed that [[Cannabis (drug)|marijuana]], when smoked, lowers intraocular pressure.<ref name="AOA">American Academy of Ophthalmology.[http://www.aao.org/education/library/cta/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=1216 Complementary Therapy Assessment: Marijuana in the Treatment of Glaucoma.] Retrieved August 2, 2006.</ref> In an effort to determine whether marijuana, or drugs derived from marijuana, might be effective as a glaucoma treatment, the US National Eye Institute supported research studies from 1978 to 1984. These studies demonstrated that some derivatives of marijuana lowered intraocular pressure when administered orally, intravenously, or by smoking, but not when topically applied to the eye. Many of these studies demonstrated that marijuana&mdash; or any of its components &mdash; could safely and effectively lower intraocular pressure more than a variety of drugs then on the market. In 2003, the [[American Academy of Ophthalmology]] released a position statement asserting that "no scientific evidence has been found that demonstrates increased benefits and/or diminished risks of marijuana use to treat glaucoma compared with the wide variety of pharmaceutical agents now available."<ref name="AOA"/>
The first patient in the United States federal government's [[Compassionate Investigational New Drug program]], Robert Randall, was afflicted with glaucoma and had successfully fought charges of marijuana cultivation because it was deemed a [[medical necessity]] (''U.S. v. Randall'') in 1976.<ref>http://blogs.salon.com/0002762/stories/2005/02/18/irvRosenbergAndTheCompassi.html</ref>


==References==
==References==

Revision as of 05:06, 23 August 2012

Glaucoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Glaucoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Glaucoma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glaucoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glaucoma medical therapy

CDC on Glaucoma medical therapy

Glaucoma medical therapy in the news

Blogs on Glaucoma medical therapy

Directions to Hospitals Treating Glaucoma

Risk calculators and risk factors for Glaucoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]

Overview

Although intraocular pressure is only one major risk factors of glaucoma, lowering it via pharmaceuticals or surgery is currently the mainstay of glaucoma treatment. In Europe, Japan, and Canada laser treatment is often the first line of therapy. In the U.S., adoption of early laser has lagged, even though prospective, multi-centered, peer-reviewed studies, since the early '90s, have shown laser to be at least as effective as topical medications in controlling intraocular pressure and preserving visual field. Some studies suggest that acupuncture can be very helpful in the treatment of Glaucoma. [1] [2]

Medical Therapy

Drugs

Intraocular pressure can be lowered with medication, usually eye drops. There are several different classes of medications to treat glaucoma with several different medications in each class.

Each of these medicines may have local and systemic side effects. Adherence to medication protocol can be confusing and expensive; if side effects occur, the patient must be willing either to tolerate these, or to communicate with the treating physician to improve the drug regimen.

Poor compliance with medications and follow-up visits is a major reason for vision loss in glaucoma patients. Patient education and communication must be ongoing to sustain successful treatment plans for this lifelong disease with no early symptoms. Ophthalmologists have debated whether glaucoma eye drops should initially be started in both eyes or in just one eye (a binocular or monocular trial), but it appears either strategy is reasonable when properly interpreted. [3]

The possible neuroprotective effects of various topical and systemic medications are also being investigated.

Commonly used medications

Cannabis

Studies in the 1970s showed that marijuana, when smoked, lowers intraocular pressure.[4] In an effort to determine whether marijuana, or drugs derived from marijuana, might be effective as a glaucoma treatment, the US National Eye Institute supported research studies from 1978 to 1984. These studies demonstrated that some derivatives of marijuana lowered intraocular pressure when administered orally, intravenously, or by smoking, but not when topically applied to the eye. Many of these studies demonstrated that marijuana— or any of its components — could safely and effectively lower intraocular pressure more than a variety of drugs then on the market. In 2003, the American Academy of Ophthalmology released a position statement asserting that "no scientific evidence has been found that demonstrates increased benefits and/or diminished risks of marijuana use to treat glaucoma compared with the wide variety of pharmaceutical agents now available."[4]

References

  1. Clinical application of acupuncture in ophthalmology. Dabov S; Goutoranov G; Ivanova R; Petkova N Acupunct Electrother Res 1985, 10 (1-2) p79-93
  2. New Peer Reviewed Study treating open angle glaucoma with acupuncture, [1]
  3. Interpretation of uniocular and binocular trials of glaucoma medications: an observational case series,[2]
  4. 4.0 4.1 American Academy of Ophthalmology.Complementary Therapy Assessment: Marijuana in the Treatment of Glaucoma. Retrieved August 2, 2006.

Template:WH

Template:WS